Carol Conrad

Associate Professor of Pediatrics (Pulmonary Medicine) at Lucile Salter Packard Children's Hospital

Professional Education

Residency: Children's Hospital of Los Angeles (1992) CAUnited States of America

Internship: Children's Hospital of Los Angeles (1990) CAUnited States of America

Board Certification: Pediatric Pulmonary, American Board of Pediatrics (1996)

Fellowship: Johns Hopkins University (1995) MD

Medical Education: UCLA Medical Center (1989) CA

Fellow, The Johns Hopkins University, Pediatric Pulmonary Medicine (1995)

BA, Univ. of California, Berkeley, Anatomy and Physiology (1983)

MD, Drew-UCLA School of Medicine, Medicine (1989)

Administrative Appointments

Director, Pediatric Pulmonary Function Lab (2004 - Present)

Director, Pediatric Lung and Heart-Lung Transplant Program (2004 - Present)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs
Makam, M., Diaz, D., Laval, J., Gernez, Y., Conrad, C. K., & Tirouvanziam, R. (2009). Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(14), 5779-5783.

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs
Makam Megha, Diaz D, Laval J, Gernez Y, & Conrad CK. (2009). Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci, 106(14).

Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation
Danziger-Isakov, L. A., Worley, S., Arrigain, S., Aurora, P., Ballmann, M., & Faro, A. (2008). Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 27(6), 655-661.

Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways
Tirouvanziam, R., Gernez, Y., Conrad, C. K., Moss, R. B., Schrijver, I., & Herzenberg, L. A. (2008). Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105(11), 4335-4339.

Variability in immunization guidelines in children before and after lung transplantation
Benden, C., Danziger-Isakov, L. A., Astor, T., Aurora, P., Bluemchen, K., & Boehler, A. (2007). Variability in immunization guidelines in children before and after lung transplantation. PEDIATRIC TRANSPLANTATION, 11(8), 882-887.

Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
Geller, D. E., Konstan, M. W., Smith, J., Noonberg, S. B., & Conrad, C. (2007). Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety. PEDIATRIC PULMONOLOGY, 42(4), 307-313.

Risk factors for small bowel bacterial overgrowth in cystic fibrosis
Fridge, J. L., Conrad, C., Gerson, L., Castillo, R. O., & Cox, K. (2007). Risk factors for small bowel bacterial overgrowth in cystic fibrosis. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 44(2), 212-218.

American society of transplantation executive summary on pediatric lung transplantation
Faro, A., Mallory, G. B., Visner, G. A., Elidemir, O., Mogayzel, P. J., & Waltz, D. A. (2007). American society of transplantation executive summary on pediatric lung transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 7(2), 285-292.

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis
Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., & Herzenberg, L. A. (2006). High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103(12), 4628-4633.

Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome
Sheridan, M. B., Fong, P. Y., Groman, J. D., Conrad, C., Flume, P., & Cutting, G. R. (2005). Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. HUMAN MOLECULAR GENETICS, 14(22), 3493-3498.

Does bacterial colonization play a role in acute respiratory failure in chronic obstructive pulmonary disease?
Conrad, C. (2005). Does bacterial colonization play a role in acute respiratory failure in chronic obstructive pulmonary disease?. CRITICAL CARE MEDICINE, 33(9), 2130-2131.

Evaluation of exposure and health care worker response to nebulized administration of tgAAVCF to patients with cystic fibrosis
Croteau, G. A., Martin, D. B., Camp, J., Yost, M., Conrad, C., & Heald, A. E. (2004). Evaluation of exposure and health care worker response to nebulized administration of tgAAVCF to patients with cystic fibrosis. ANNALS OF OCCUPATIONAL HYGIENE, 48(8), 673-681.

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study
Flotte, T. R., Zeitlin, P. L., Reynolds, T. C., Heald, A. E., Pedersen, P., & Guggino, W. B. (2003). Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study. HUMAN GENE THERAPY, 14(11), 1079-1088.

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies
Wagner, J. A., Nepomuceno, I. B., Messner, A. H., Moran, M. L., Batson, E. P., & Gardner, P. (2002). A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. HUMAN GENE THERAPY, 13(11), 1349-1359.

Paradoxical vocal cord motion in a child presenting with cyanosis and respiratory failure.
Falco, D. A., Hammer, G. B., Conrad, C., & Messner, A. H. (2002). Paradoxical vocal cord motion in a child presenting with cyanosis and respiratory failure. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 3(2), 185-186.

Clinical infection control in gene therapy: A multidisciplinary conference
Evans, M. E., Jordan, C. T., Chang, S. Mw., Conrad, C., Gerberding, J. L., & Wivel, N. A. (2000). Clinical infection control in gene therapy: A multidisciplinary conference. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 21(10), 659-673.

Safety and biological efficacy of an adeno-associated virus vector cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus
Wagner, J. A., Messner, A. H., Moran, M. L., DAIFUKU, R., Kouyama, K., & Gardner, P. (1999). Safety and biological efficacy of an adeno-associated virus vector cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. LARYNGOSCOPE, 109(2), 266-274.

A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis
Wagner, J. A., Moran, M. L., Messner, A. H., DAIFUKU, R., Conrad, C. K., & Gardner, P. (1998). A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis. HUMAN GENE THERAPY, 9(6), 889-909.

Safety of single-dose administration of an adenoassociated virus (AAV)-CFTR vector in the primate lung
Conrad, C. K., Allen, S. S., Afione, S. A., Reynolds, T. C., Beck, S. E., & Flotte, T. R. (1996). Safety of single-dose administration of an adenoassociated virus (AAV)-CFTR vector in the primate lung. GENE THERAPY, 3(8), 658-668.

A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease
Flotte, T., Carter, B., Conrad, C., Guggino, W., Reynolds, T., & Wetzel, R. (1996). A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. HUMAN GENE THERAPY, 7(9), 1145-1159.

In vivo model of adeno-associated virus vector persistence and rescue
Afione, S. A., Conrad, C. K., Kearns, W. G., Chunduru, S., Adams, R., & Flotte, T. R. (1996). In vivo model of adeno-associated virus vector persistence and rescue. JOURNAL OF VIROLOGY, 70(5), 3235-3241.

ALVEOLAR STEM-CELL TRANSDUCTION BY AN ADENOASSOCIATED VIRAL VECTOR
Zeitlin, P. L., Chu, S., Conrad, C., MCVEIGH, U., Ferguson, K., & Guggino, W. B. (1995). ALVEOLAR STEM-CELL TRANSDUCTION BY AN ADENOASSOCIATED VIRAL VECTOR. GENE THERAPY, 2(9), 623-631.

GENE-THERAPY VECTORS AS DRUG-DELIVERY SYSTEMS
Afione, S. A., Conrad, C. K., & Flotte, T. R. (1995). GENE-THERAPY VECTORS AS DRUG-DELIVERY SYSTEMS. CLINICAL PHARMACOKINETICS, 28(3), 181-189.

HEMOTHORAX IN A CHILD AS A RESULT OF COSTAL EXOSTOSIS
TOMARES, S. M., Jabra, A. A., Conrad, C. K., Beauchamp, N., Phoon, C. K., & Carroll, J. L. (1994). HEMOTHORAX IN A CHILD AS A RESULT OF COSTAL EXOSTOSIS. PEDIATRICS, 93(3), 523-525.

STABLE IN-VIVO EXPRESSION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR WITH AN ADENOASSOCIATED VIRUS VECTOR
Flotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., & Carter, B. J. (1993). STABLE IN-VIVO EXPRESSION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR WITH AN ADENOASSOCIATED VIRUS VECTOR. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 90(22), 10613-10617.

PROTEINS BUT NOT AMINO-ACIDS, CARBOHYDRATES, OR FATS STIMULATE CHOLECYSTOKININ SECRETION IN THE RAT
Liddle, R. A., Green, G. M., Conrad, C. K., & Williams, J. A. (1986). PROTEINS BUT NOT AMINO-ACIDS, CARBOHYDRATES, OR FATS STIMULATE CHOLECYSTOKININ SECRETION IN THE RAT. AMERICAN JOURNAL OF PHYSIOLOGY, 251(2), G243-G248.

REGULATION OF GASTRIC-EMPTYING IN HUMANS BY CHOLECYSTOKININ
Liddle, R. A., Morita, E. T., Conrad, C. K., & Williams, J. A. (1986). REGULATION OF GASTRIC-EMPTYING IN HUMANS BY CHOLECYSTOKININ. JOURNAL OF CLINICAL INVESTIGATION, 77(3), 992-996.